Victory Capital Management Inc Regenerx Biopharmaceuticals Inc Put Options Transaction History
Victory Capital Management Inc
- $95.8 Billion
- Q2 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
About REGENERX BIOPHARMACEUTICALS INC
- Ticker RGRX
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,550,000
- Description
- RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; ...